ROANOKE, Va. (WDBJ) – Pfizer said it plans to seek regulatory approval of a new vaccine for Lyme disease.
Vaccines for Lyme disease have had a troubled past. One was approved in 1998. Its manufacturer pulled it from the market in 2002 due to soft demand. That was based largely on fears it caused arthritis, even though the FDA concluded it didn’t.
Nearly half a million people are diagnosed and treated for Lyme disease in the U.S. every year. The disease is caused by a bacteria found in blacklegged ticks. If it isn’t treated, the infection can spread to the joints, heart and nervous system.
Kratom poisoning calls surge
Researchers found calls to poison centers about the psychoactive herb have surged more than 1,200 percent over the last decade…